Total planned funding: $129,779,493
Allocations
Countries/Regions
India | $129,779,493 |
Organizational Types
NGO | $47,998,060 |
Unknown | $32,934,736 |
Own Agency | $21,898,813 |
University | $14,932,112 |
Private Contractor | $3,339,272 |
Implementing Agency | $3,100,000 |
Multi-lateral Agency | $2,010,000 |
Host Country Government Agency | $1,539,200 |
FBO | $1,400,000 |
Other USG Agency | $627,300 |
Program Areas
Governance and Systems | $59,140,291 |
Prevention | $28,545,583 |
Management and Operations | $16,298,170 |
Care | $15,565,738 |
Treatment | $5,393,829 |
Testing | $4,835,882 |
Budget Codes
OHSS: Health Systems Strengthening | $36,180,735 |
HVSI: Strategic Information | $18,458,939 |
HVOP: Sexual Prevention: Other Sexual Prevention | $17,770,242 |
HVMS: Management and Operations | $16,298,170 |
HBHC: Care: Adult Care and Support | $7,609,505 |
HTXS: Treatment: Adult Treatment | $4,877,194 |
HVCT: Testing: HIV Testing and Counseling | $4,835,882 |
HLAB: Laboratory Infrastructure | $4,500,617 |
HKID: Care: Orphans and Vulnerable Children | $3,935,771 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,264,396 |
HVTB: Care: TB/HIV | $3,197,122 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $3,112,090 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $3,089,202 |
HMBL: Biomedical Prevention: Blood Safety | $1,299,653 |
PDCS: Care: Pediatric Care and Support | $823,340 |
PDTX: Treatment: Pediatric Treatment | $493,158 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$32,310,247
Countries/Regions
Voluntary Health Services:
$11,360,000
Countries/Regions
USG Aggregated Agencies:
$11,330,746
Countries/Regions
FHI 360:
$10,614,825
Countries/Regions